Literature DB >> 15868983

Stroke in sickle cell disease in Africa: case report.

J Makani1.   

Abstract

Stroke, including asymptomatic cerebrovascular events, is a significant cause of morbidity and mortality in sickle cell disease, occurring with an incidence of 10 to 25%. Extensive research has established that cerebral stenosis, involving the circle of Willis, is the most common mechanism in children. We report a child with sickle cell disease who presented with cortical blindness and right-sided hemiplegia. Computerised tomography of the brain revealed an infarct involving the left parietal region and extending to the occipital region. Stroke in SCD is multifactorial, but high-risk individuals can be identified by simple well-established strategies such as transcranial doppler ultrasonography. There are approaches for both primary and secondary interventions, which have been shown to be effective and need to be incorporated into management guidelines for SCD patients. Before schemes are recommended into health care policies, research in the appropriate setting is required.

Entities:  

Mesh:

Year:  2004        PMID: 15868983      PMCID: PMC5612386          DOI: 10.4314/eamj.v81i12.9253

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  17 in total

1.  Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease.

Authors:  J Schatz; R T Brown; J M Pascual; L Hsu; M R DeBaun
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

Review 2.  New advances in the treatment of sickle cell disease: focus on perioperative significance.

Authors:  H M Dix
Journal:  AANA J       Date:  2001-08

Review 3.  Stroke in children: recognition, treatment, and future directions.

Authors:  G deVeber; E S Roach; A R Riela; M Wiznitzer
Journal:  Semin Pediatr Neurol       Date:  2000-12       Impact factor: 1.636

Review 4.  Stroke prevention and treatment in sickle cell disease.

Authors:  R J Adams
Journal:  Arch Neurol       Date:  2001-04

5.  Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease.

Authors:  K J Wierenga; B E Serjeant; G R Serjeant
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

6.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

7.  The use of transcranial ultrasonography to predict stroke in sickle cell disease.

Authors:  R Adams; V McKie; F Nichols; E Carl; D L Zhang; K McKie; R Figueroa; M Litaker; W Thompson; D Hess
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

8.  Neuropsychologic and academic functioning of children with sickle cell anemia.

Authors:  M G Fowler; J K Whitt; R R Lallinger; K B Nash; S S Atkinson; R J Wells; C McMillan
Journal:  J Dev Behav Pediatr       Date:  1988-08       Impact factor: 2.225

9.  Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI.

Authors:  R J Adams; F T Nichols; V McKie; K McKie; P Milner; T E Gammal
Journal:  Neurology       Date:  1988-07       Impact factor: 9.910

10.  Contribution of sickle cell disease to the occurrence of developmental disabilities: a population-based study.

Authors:  A Ashley-Koch; C C Murphy; M J Khoury; C A Boyle
Journal:  Genet Med       Date:  2001 May-Jun       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.